These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 3393618

  • 21. Relationships of the dexamethasone suppression test to clinical severity and degree of melancholia.
    Kumar A, Alcser K, Grunhaus L, Greden JF.
    Biol Psychiatry; 1986 May; 21(5-6):436-44. PubMed ID: 3697434
    [Abstract] [Full Text] [Related]

  • 22. Morning and evening adrenocortical responses to ACTH stimulation in endogenously depressed patients: a preliminary report.
    Shimoda K, Yamada N, Hanada K, Tsujimoto T, Takahashi S, Takahashi K.
    Jpn J Psychiatry Neurol; 1989 Mar; 43(1):57-62. PubMed ID: 2544755
    [Abstract] [Full Text] [Related]

  • 23. Self-reported diurnal mood changes, early morning awakening and the dexamethasone suppression test in endogenous depression.
    Grunhaus L, Flegel P, Carroll BJ, Greden JF.
    J Affect Disord; 1985 Mar; 8(1):1-7. PubMed ID: 3156907
    [Abstract] [Full Text] [Related]

  • 24. Does the dexamethasone suppression test relate to subtypes, factors, symptoms, or severity?
    Miller KB, Nelson JC.
    Arch Gen Psychiatry; 1987 Sep; 44(9):769-74. PubMed ID: 3632250
    [Abstract] [Full Text] [Related]

  • 25. Pharmacologic provocation and dexamethasone suppression test sensitivity.
    Swartz CM, Breen K, Wahby VS.
    Neuropsychobiology; 1989 Sep; 22(1):11-3. PubMed ID: 2700773
    [Abstract] [Full Text] [Related]

  • 26. Age and the dexamethasone suppression test in depression.
    Davis KL, Davis BM, Mathé AA, Mohs RC, Rothpearl AB, Levy MI, Gorman LK, Berger P.
    Am J Psychiatry; 1984 Jul; 141(7):872-4. PubMed ID: 6731636
    [Abstract] [Full Text] [Related]

  • 27. The dexamethasone suppression test in dementia: a review of the literature.
    Skare S, Pew B, Dysken M.
    J Geriatr Psychiatry Neurol; 1990 Jul; 3(3):124-38. PubMed ID: 2282129
    [Abstract] [Full Text] [Related]

  • 28. Plasma dexamethasone concentrations and differential suppression response of cortisol and corticosterone in depressives and controls.
    Holsboer F, Haack D, Gerken A, Vecsei P.
    Biol Psychiatry; 1984 Mar; 19(3):281-91. PubMed ID: 6722226
    [Abstract] [Full Text] [Related]

  • 29. Dexamethasone suppression test in depressive stroke patients.
    Dam H, Pedersen HE, Damkjaer M, Ahlgren P.
    Acta Neurol Scand; 1991 Jul; 84(1):14-7. PubMed ID: 1927256
    [Abstract] [Full Text] [Related]

  • 30. The dexamethasone suppression index: enhancement of DST diagnostic utility for depression by expressing serum cortisol as a function of serum dexamethasone.
    Arana GW, Reichlin S, Workman R, Haaser R, Shader RI.
    Am J Psychiatry; 1988 Jun; 145(6):707-11. PubMed ID: 3369557
    [Abstract] [Full Text] [Related]

  • 31. [Correlations between clinico-psychiatric findings and the dexamethasone suppression test in depression].
    Rupprecht R, Barocka A, Pichl J.
    Psychiatr Prax; 1988 Jul; 15(4):142-5. PubMed ID: 3406225
    [Abstract] [Full Text] [Related]

  • 32. Seasonal variation and the results of the dexamethasone suppression test.
    Harris B, Watkins S, Newcombe R, Cook N, Read G, Riad-Fahmy D.
    J Affect Disord; 1990 Oct; 20(2):115-20. PubMed ID: 2148325
    [Abstract] [Full Text] [Related]

  • 33. The plasma dexamethasone window: evidence supporting its usefulness to validate dexamethasone suppression test results.
    O'Sullivan BT, Hunt GE, Johnson GF, Caterson ID.
    Biol Psychiatry; 1989 Mar 15; 25(6):739-54. PubMed ID: 2923936
    [Abstract] [Full Text] [Related]

  • 34. Clinical correlates of response to DST. The Dexamethasone Suppression test in depression: a World Health Organisation collaborative study.
    Gastpar M, Gilsdorf U, Abou-Saleh MT, Ngo-Khac T.
    J Affect Disord; 1992 Sep 15; 26(1):17-24. PubMed ID: 1430664
    [Abstract] [Full Text] [Related]

  • 35. The 2-mg dexamethasone suppression test in differentiating major depression with psychosis from schizophrenia.
    Clower CG.
    J Clin Psychopharmacol; 1986 Dec 15; 6(6):363-5. PubMed ID: 3805330
    [Abstract] [Full Text] [Related]

  • 36. Dexamethasone suppression test in severe schizophrenic illness: effects of plasma dexamethasone and caffeine levels.
    Holsboer-Trachsler E, Buol C, Wiedemann K, Holsboer F.
    Acta Psychiatr Scand; 1987 Jun 15; 75(6):608-13. PubMed ID: 3618283
    [Abstract] [Full Text] [Related]

  • 37. Seasonal variations of the dexamethasone suppression test in depression compared with schizophrenia: a gender effect.
    Rybakowski J, Plocka M.
    J Affect Disord; 1992 Feb 15; 24(2):87-91. PubMed ID: 1541770
    [Abstract] [Full Text] [Related]

  • 38. Dexamethasone suppression test, TRH test and Newcastle II depression rating in the diagnosis of depressive disorders.
    Larsen JK, Bjørum N, Kirkegaard C, Aggernaes H, Krog-Meyer I, Lund-Laursen AM, Mikkelsen PL.
    Acta Psychiatr Scand; 1985 May 15; 71(5):499-505. PubMed ID: 3925727
    [Abstract] [Full Text] [Related]

  • 39. The DST and posttraumatic stress disorder.
    Kudler H, Davidson J, Meador K, Lipper S, Ely T.
    Am J Psychiatry; 1987 Aug 15; 144(8):1068-71. PubMed ID: 3605429
    [Abstract] [Full Text] [Related]

  • 40. Postdexamethasone plasma cortisol and beta-endorphin levels in depression: relationship to severity of illness.
    Meador-Woodruff JH, Haskett RF, Grunhaus L, Akil H, Watson SJ, Greden JF.
    Biol Psychiatry; 1987 Sep 15; 22(9):1137-50. PubMed ID: 2958096
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.